New combo may treat kidney cancer without removing the organ
NCT ID NCT07233252
First seen Nov 18, 2025 · Last updated May 25, 2026 · Updated 32 times
Summary
This study tests whether a combination of two drugs (tislelizumab and nab-paclitaxel) can treat renal pelvic cancer while avoiding removal of the kidney. About 35 adults with early-stage cancer that hasn't spread will receive the drugs, and if the tumor shrinks enough, they may get additional treatment through a scope to destroy any remaining cancer. The main goal is to see if the kidney can be saved for at least one year without needing surgery to remove it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TISLELIZUMAB are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Hospital of Tianjin Medical University
RECRUITINGTianjin, Outside U.S., 300211, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.